Prospective Open-Label Study of the Emergence of Drug Resistance in Patients Infected With HIV-1 Who Are Taking Oral U-87201E
NCT00002094
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
HIV Infections
Interventions
DRUG:
Atevirdine mesylate
Sponsor
Pharmacia and Upjohn